Earnings Per Share, Diluted of BriaCell Therapeutics Corp. from 31 Jan 2022 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
BriaCell Therapeutics Corp. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Jan 2022 to 31 Jan 2026.
  • BriaCell Therapeutics Corp. Earnings Per Share, Diluted for the quarter ending 31 Jan 2026 was -2.58, a 89% increase year-over-year.
  • BriaCell Therapeutics Corp. Earnings Per Share, Diluted for the twelve months ending 31 Jan 2026 was -13.14, a 85% increase year-over-year.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Diluted for 2025 was -62.19, a 42% decline from 2024.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Diluted for 2024 was -43.68, a 3260% decline from 2023.
  • BriaCell Therapeutics Corp. annual Earnings Per Share, Diluted for 2023 was -1.3, a 25% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -13.14 -2.58 +20.73 +89% 01 Nov 2025 31 Jan 2026 10-Q 10 Mar 2026 2026 Q2
Q3 2025 -33.87 -4.35 +28.32 +87% 01 Aug 2025 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 -62.19 -4.57 +29.58 +87% 01 May 2025 31 Jul 2025 10-K 16 Oct 2025 2025 FY
Q1 2025 -91.77 -1.64 -3.25 -202% 01 Feb 2025 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 -88.52 -23.31 -12.67 -119% 01 Nov 2024 31 Jan 2025 10-Q 10 Mar 2026 2026 Q2
Q3 2024 -75.85 -32.67 -32.17 -6434% 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2025 2026 Q1
Q2 2024 -43.68 -34.15 -34.01 -24293% 01 May 2024 31 Jul 2024 10-K 16 Oct 2025 2025 FY
Q1 2024 -9.67 1.61 +1.93 01 Feb 2024 30 Apr 2024 10-Q 16 Jun 2025 2025 Q3
Q4 2023 -11.6 -10.64 -9.87 -1282% 01 Nov 2023 31 Jan 2024 10-Q 12 Mar 2025 2025 Q2
Q3 2023 -1.73 -0.5 -0.43 -614% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q2 2023 -1.3 -0.14 01 May 2023 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 -0.32 +0.33 +51% 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q3
Q4 2022 -0.77 -0.81 -2025% 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024 2024 Q2
Q3 2022 -0.07 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023 2024 Q1
Q1 2022 -0.65 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023 2023 Q3
Q4 2021 0.04 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q2

BriaCell Therapeutics Corp. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -62.19 -18.51 -42% 01 Aug 2024 31 Jul 2025 10-K 16 Oct 2025 2025 FY
2024 -43.68 -42.38 -3260% 01 Aug 2023 31 Jul 2024 10-K 16 Oct 2025 2025 FY
2023 -1.3 +0.43 +25% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 -1.73 01 Aug 2021 31 Jul 2022 10-K 25 Oct 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.